Professional Documents
Culture Documents
The explanatory on rural development stages using geographically weighted regression based
on the integration of socio-economic, demographical and landcover data
AIP Conference Proceedings 2563, 060001 (2022); https://doi.org/10.1063/5.0103235
New information of plants with potential as traditional medicine from tangale natural reserve,
Gorontalo Province – Sulawesi
AIP Conference Proceedings 2563, 050006 (2022); https://doi.org/10.1063/5.0121530
© 2022 Author(s).
Local Culture of Kratom (Mitragyna speciosa) Consumption
in Kapuas Hulu District
Rudy Setyo Utomo1, a), M. Agus Wibowo2, b), Nurmainah3, c), Rusli Burhansyah4, d)
1
Research and Development Agency of West Kalimantan Province,
Jl. Dr. Sutomo No.1, Sungai Bangkong, Pontianak Kota, Pontianak, Kalimantan Barat 78113, Indonesia
2
Department of Chemistry, Faculty of Mathematisc and Natural Sciences, Tanjungpura University,
Jl. Prof. Dr. H. Hadari Nawawi, Bansir Laut, Pontianak Tenggara, Pontianak, Kalimantan Barat 78124, Indonesia
3
Department of Pharmacy, Faculty of Medicine, Tanjungpura University,
Jl. Prof. Dr. H. Hadari Nawawi, Bansir Laut, Pontianak Tenggara, Pontianak, Kalimantan Barat 78124, Indonesia
4
Center for Agricultural Technology Assessment of West Kalimantan Province,
Jl. Budi Utomo No. 45, Siantan Hulu, Pontianak Utara, Pontianak, Kalimantan Barat 78241, Indonesia
a)
Corresponding author: rudystyo@gmail.com
b)
m. agusw7317@gmail.com
c)
nurmainah@pharm.untan.ac.id
d)
rburhansyah@gmail.com
Abstract. Kratom leaves (Mitragyna speciosa Korth) have been used by people in West Kalimantan, especially Kapuas
Hulu District, as local culture, for traditional medicine. This research was conducted to obtain facts and data on utilization
and complaints due to the use of kratom leaves in local culture by the people of Kapuas Hulu Regency. Data obtained by
interview using a questionnaire and the determination of the respondents is done by snowball. The relationship between
period, dose and frequency of kratom leaf consumption and complaints was searched statistically using the chi-quadrate. It
was found that 152 respondents who consumed kratom leaves. The main reason respondents consume kratom leaves to
overcome fatigue or get stamina (49%) and to treat illness 25%. Generally, 46% of respondents consume kratom leaves for
less than 1 year, although 25% of them are more than 5 years. Most of the respondents consumed kratom leaf powder at a
dose of ¼ teaspoon (0.5 g) with the highest frequency once a day (27.94%). Chi-square analysis showed that there was no
very significant relationship between the period of drinking kratom leaves and complaints, but there was a very significant
relationship between the dose of kratom leaf consumption and complaints and between the frequency of drinking kratom
leaves and complaints. There were no complaints such as symptoms of narcotics and drug users. Generally, respondents
stated that they did not experience complaints 93.42%. About 6.58% of complaints were feeling tired, drowsy and achy.
INTRODUCTION.
Kratom leaf (Mitragyna speciosa Korth) (MS) is an indigenous plant of West Kalimantan, especially in the districts
of Kapuas Hulu, Melawi, Ketapang, Sekadau, and Tayan. The leaves of this plant have been traded and play a role as
one of the community's economic income. In local culture, the leaves of this plant are often used as herbal medicines
to treat several diseases such as diarrhea, pain relief (analgesic), fever, cough, hypertension (high blood pressure),
impotence, diabetes [1,2] and anti-inflammatory [3]. In Southeast Asia, kratom is commonly used for stimulants to
strengthen endurance, analgesics (pain relievers) and sedatives [4], sex disorder, treat opioid addiction and prevent
fatigue [3-5], postpartum recovery [6]. In vivo and/or in vitro assays show MS and its active compounds have
anticancer [7], cardiovascular disease [8] and antibacterial actions [9].
Alkaloid compounds are the content in kratom leaves that play a very important role in medicine. The content of
alkaloids in kratom leaves ranges from 0.5-1.5% [10]. Mitragynine (MG) or 9-methoxy corynantheidine is the main
active alkaloid in Kratom leaves. The MG content is about 12% (w/w) of the total alkaloid content in Kratom from
The 2nd Universitas Lampung International Conference on Science, Technology, and Environment (ULICoSTE) 2021
AIP Conf. Proc. 2563, 050026-1–050026-11; https://doi.org/10.1063/5.0104736
Published by AIP Publishing. 978-0-7354-4237-5/$30.00
050026-1
Malaysia and 66% (w/w) from Kratom from Thailand [11,12]. Meanwhile, Warner et al [10] stated that the MG
content was close to 60% and 7-hydroxy mitragynine (7-HMG) was only 2% of the total alkaloid content of kratom
leaves. The level of MG content in kratom leaves from Southeast Asia varies between 0.39%-1.43% w/w [12,13].
Kratom leaves are consumed by brewing [3,5], chewed, smoked, taken in capsules [3], or for cigarettes [2].
Consumption of kratom leaves in several articles has been stated to have a stimulant effect and gives effects such as
opioids [4] and several other articles show benefits as amazing drugs [2,3]. Meireles et al [2] stated that the
consumption of high doses of kratom leaves for a long period of time has the effect of irritability, anxiety and increased
aggression, so the use of this drug freely is prohibited.
MG is the dominant alkaloid compound contained in kratom leaves. MG is said to have an antinociceptive (pain
relief) effect [14]. Other researchers stated that kratom in the new market is used in a different way from its traditional
application so kratom is referred to by many as a safe psychoactive product to improve mood, reduce pain, and can
provide benefits in opiate addiction [10]. Therefore, this research was conducted. The problem is whether the
traditional way of consuming kratom leaves by residents in the kratom-producing areas of origin has a beneficial or
detrimental effect? The purpose of this study was to find out the complaints and benefits of consuming kratom leaves
by local people in the kratom-producing areas of origin.
METHOD
The research was carried out in 2020 for 8 months from March 2020 to October 2020 with the location of Kapuas
Hulu Regency which is a place for cultivation, production, processing and trading of kratom leaves. Data obtained by
questionnaires and structured interviews. Respondents were characterized by age, gender, last education, type of work,
and residential address. The research sample was 152 respondents (n), 11 districts were selected to produce the most
kratom leaves. Respondents were tracked by the snowball method. The total population in 11 sub-districts is 145,872
people (N), so the error rate e is 0.0811 according to Slovin's equation (1):
ࡺ
ൌ (1)
ࡺǤ ࢋ
Age respondents were grouped according to WHO Standard [15], namely: 20-24; 25-29; 30-34; 35-39; 40-44; 45-
49; 50-54; 55-59; 60-64; 65-69; and 70-74. The data are grouped into main categories, namely (1) data on the use of
kratom leaves as traditional medicines and (2) data on complaints caused by consumption of kratom leaves.
Data on the use of kratom leaves as traditional medicines, namely: (1) lowering high blood pressure, (2) relieving
pain, (3) aches and pains, (4) tiredness, (5) treating alcoholism, (6) maintaining and increasing stamina, (7) treat
impotence, (8) treat wounds, (9) relieve itching on the skin, (10) treat coughs, (11) relieve diarrhea and abdominal
pain, (12) reduce fever, (13) treat malaria, (14) treat impotence, (15) treat diabetes, and (16) others.
Complaint data are grouped into complaints commonly experienced by users and complaints such as the result of
the use of narcotics and illegal drugs, namely: (1) aches, (2) emotional, (3) sleepy, (4) fatigue, (5) anxiety, (6)
nauseous/vomit, (7) frequent colds, (8) often sickly, (9) afternoon mouth, (10) headache, (11) excessive thirst, (12)
exessive sweathing, (13) sore or bruises, ( 14) frequent nosebleeds, (15) sudden weight gain or loss, (16) seizures
without a history of epilepsy, (17) shaky, (18) flushed face and cheeks, (19) depression, and (20) no complaints.
Data on kratom leaf consumption were grouped into: (A) length of time of consumption (period), namely (1) to 1
week, (2) more than 1 week to less than 1 month (3) more than 1 month to 1 year, (4) more than 1 year to 5 years (5)
more than 5 years to 10 years, (6) more than 10 years. (B) consumption dose data, namely (1) 1/4 teaspoon (2) 1/2
teaspoon, (3) 1 teaspoon, (4) 1/2 tablespoon, (5) 1 tablespoon, and (6) more than 1 tablespoons. (C) Frequency of
consumption of kratom leaves, namely: (1) once a day, (2) twice a day, (3) three times a day, (4) more than twice a
day, (5) once a week, (6) twice a week, (7) three times a week, (8) four times a week, (9) once a month, (10) twice a
month, and (11) three times a month.
Data related to the use of kratom leaves as traditional medicine are presented proportionally. While the data on the
relationship between the use of kratom leaves and complaints were tabulated and analyzed by statistical chi-square
independence, namely: the period of consumption of kratom leaves with complaints, the dose of consumption of
kratom leaves with complaints, the frequency of consumption of kratom leaves with complaints. Chi-square equation
(2):
σሺܱ െ ݁ ሻଶ
ɖʹ ൌ (2)
݁
050026-2
where: χ2 = chi-square test; Orc = observed value in row r column c; erc = expected value in row r column c. The
statistical analysis of chi-quadrate independence was carried out using the help of IBM SPSS ver 22.
Respondent characteristics
Respondents who consumed kratom leaves 152 people. Respondents consuming kratom leaves are between 15 to
74 years old (see Fig. 1). The age of most respondents consuming kratom leaves is between 35 to 39 years old.
35 160
31 142
30 140
26
120
25
19 18 100
20
people
people
17 16
80
15
60
10 8 7 40
4 3
5 2 20 10
1
0 0
male
female
15 - 19
35 - 39
45 - 49
40 - 44
30 - 34
50 - 54
20 - 24
25 - 29
55 - 59
65 - 69
60 - 64
70 - 74
FIGURE 1. Age distribution of respondents. FIGURE 2. Number of male and female respondents
There were 142 male and 10 female respondents (data in Fig. 2). The level of education, mostly 90 people
graduated from high school, 28 people graduated from junior high school, 21 people graduated from elementary
school, and 13 people graduated from college.
The distribution of the number of respondents who consume kratom leaves according to the type of work is as
follows: respondents who get income from the private sector are 67 people, farmers and fishermen are 63 people,
government employees/Police/Indonesian National Army 18 people, students/college students 2 people, labor 1
person, and not working 1 person.
050026-3
The sprinkling of kratom leaf powder on the skin is intended for external treatment such as itching and wounds due to
incisions or external wounds that cause infection of the skin.
050026-4
tablespoon or more than 1 tablespoon is the dose that is generally used irregularly to consume kratom leaves or to be
drunk by more than 1 person.
Consumption of kratom leaves in the form of crumbs (coarser than powder size) was 19% of the total kratom
drinker respondents' statements. The dose of consumption of kratom leaves in the form of crumbs is more than 1
tablespoon as much as 24%. Medium for consumption of teaspoon (0.72 g) and teaspoon at the proportion of 21%
each. The dose of consumption 1 tablespoon (2.88 g) 14%. The least consumption of crumbs is tablespoon as much
as 2%.
The respondents who consumed fresh leaf sheets were 32.13%. The highest number of leaves consumed was 2 to
5 fresh kratom leaves, boiled and after cooling the water was drunk (49.30%). Water for boiling is generally less than
1 liter of clean water. If the leaves are boiled 6 to 10 sheets as much as 25.35% with the amount of water to dissolve
is 1 to 2 liters. Doses of more than 10 kratom leaves are usually used for several drinks in a few days or taken by more
than 1 person.
The frequency of drinking kratom leaves by respondents was 1 day 1 time by 27.94%, the next 1 week 4 times
11.27%, 1 month 3 times 10.78%, 1 month 2 times 10.29% and 1 month 1 time 10.29%. The highest frequency is 1
day 3 times as much as 0.98%. The proportion of kratom leaf consumers who drink it by mixing it with other
ingredients is 39.88% and not mixed with other ingredients is more than 60.12%. The mixture that is commonly used
is honey with 52.76%, coffee as much as 3.68%, lime 1.23%, and tea, 0.61%, while other mixtures 1.23% are ginger
or palm sugar.
Kapuas Hulu Regency is a source of kratom leaf production so that many people consume kratom leaves. Consume
in the form of powder, crumbs and fresh leaves. People say kratom leaves are used in various treatments to maintain
and increase stamina, overcome fatigue, reduce high blood pressure, relieve aches and pains, treat wounds, relieve
pain, relieve diarrhea and abdominal pain, treat diabetes, treat alcoholism, treat coughs, treat malaria, treat impotence,
relieve itching on the skin, and reduce fever.
050026-5
These statements are in accordance with the statement of local wisdom in Malaysia. Some Malaysians who
consume kratom leaves state that Kratom increases strength, lowers blood pressure, treats diarrhea, as an anxiolytic,
and antidiabetic [16]. Veltri and Grundmann [4] also stated observations of the traditional use of Kratom leaves as a
wound dressing, to reduce fever, and to reduce symptoms of opium and heroin addiction [4]. Proof of anti-pain
properties was carried out by Mossadeq et al [17] and Goh et al [7], methanol extract of kratom leaves has strong
analgesic, antinociceptive and anti-inflammatory properties in mice. The ethanol extract contains bioactive indole
alkaloids, namely mitragynine and paynantheine and flavonols, namely quercetin and rutin [7].
In Western countries, Veltri and Grundmann [4] reported that most respondents use Kratom to relieve acute or
chronic pain and to reduce emotional and mental stress, increase energy, increase focus, improve depressed mood,
reduce anxiety levels, and reduce stress or stop using opioids.
As a traditional medicine for wounds and diarrhea or stomach pain, it has been tested, kratom leaf extract has
antibacterial activity, including against Aeromonas hydrophilla [18], Salmonella typhi and Bacillus subtilis [9],
Staphylococcus epidermidis [19], and antifungal of Schizophyllum commune [20].
state a complaint 10
- 50 100 150
number of respondent
a
050026-6
no complaint 128
feel tired 11
sleepy 10
aches and pain 10
nausea and vomiting 8
sudden weight gain or loss 1
excessive sweating 1
excessive thirst 1
headache 1
often sick 1
depression 0
blushing face and cheeks 0
Shaky 0
seizures without a history of epilepsy 0
frequent nosebleeds 0
skin sores or bruises 0
sore mouth 0
frequent colds 0
anxiety 0
emotional 0
0 50 100 150
number of statement
b
FIGURE 6. The number of respondent statements: a. who stated that there were complaints and no
complaints, b. a common complaint and complaints such as symptoms of consumption of narcotics
and illegal drugs
So far, no incidents of death or toxicity directly related to kratom use have been reported in Asian countries [25].
Some rules for consumption and distribution of kratom vary in different countries. MS, mitragynine, or 7-
hydroxymitragynine is controlled only in a small number of European Union (EU) Member States, such as Denmark,
Latvia, Lithuania, Poland, Romania and Sweden. Kratom is also largely uncontrolled in the US, with only a few states
controlling such as Indiana, Iowa, Louisiana, and Massachusetts [25]. The main pharmacologically active alkaloid in
kratom leaves is mitragynine (MG) [26,12]. Mitragynine is an indole alkaloid compound [26]. In young leaves of M.
speciosa, obtained mitragynine as the main constituent (66.2%) of alkaloid compounds, speciogynine (6.6%),
speciociliatine (0.8%), paynantheine (8.6%) and 7α-hydroxy-7H-mitragynine as constituents. minor (2.0%) [27]. MG
plays a major role as an antinociceptive agent [26]. The content of mitragynine in MS leaves varies according to
geographic location and season. It is known that the mitragynine content of M. speciosa in the Thai variety is 66% of
the total alkaloids, while the Malaysian variety only contains 12% of the total alkaloids [28]. Thus the pharmacological
effect varies according to the proportion of alkaloid compounds present, related to geographic origin, stage of maturity
and ecotype [12].
050026-7
The results of the chi-square test of the relationship between the dose of kratom leaf consumption and their
complaints showed a very significant difference, as shown in Table 1. Meanwhile, Table 3 shows that most
respondents who consumed kratom leaves at a dose of teaspoon did not experience any complaints. At the
consumption dose of 1 tablespoon of kratom leaf powder and more, there are complaints of sleepy and fatigue. Of the
52 respondents who did not experience complaints as many as 32 people and who experienced complaints as many
as 20 people, most of them complained of sleepy, fatigue and nausea or vomiting.
TABLE 1. Chi-square tests of relationship of the kratom leaf consumption with their complaints
complaint
Exes- sudden
Period Nausea- Exces-
often Head- sive weight no com- Total
aches sleepy fatigue ous/ sive
sickly ache swe- gain or plaints
vomit thirst
athing loss
less
than 1
1 1 0 1 0 0 0 0 0 3 6
week
ago
less
than 1
1 0 1 0 0 0 0 0 0 11 13
moth
ago
less
than 1
4 3 8 5 0 0 1 1 1 56 79
year
ago
less
than 5
2 0 1 0 1 0 0 0 0 19 23
years
ago
less
than
10 1 5 1 1 0 0 0 0 0 31 39
years
ago
more
than
0 1 0 1 0 1 0 0 0 3 6
10
years
Total 9 10 11 8 1 1 1 1 1 123 166
050026-8
TABLE 3. The relationship between the dose of kratom leaf consumption and the complaints
complaint
Exes- sudden
Dosage Nau- Exces- no Total
Fati- often sive weight
aches sleepy seous/ sive com-
gue sickly swea- gain or
vomit thirst plaints
thing loss
1/4 teaspoon 3 4 0 5 0 0 0 0 106 118
1/2 teaspoon 3 0 7 0 1 0 0 0 29 40
1 teaspoon 2 2 2 0 0 0 0 0 20 26
1/2
0 0 0 0 0 0 0 0 1 1
tablespoon
1 tablespoon 2 1 3 3 0 1 1 1 8 20
more than 1
0 5 2 1 0 0 0 0 24 32
tablespoon
Total 10 12 14 9 1 1 1 1 188 237
For kratom leaf drinkers at a dose of teaspoon, most of them did not experience complaints (the ratio of those who
did not complain compared to those who complained was 90%: 10%). The highest complaints were experienced by
consumers who consumed 1 tablespoon of kratom leaf powder and more than 1 tablespoon (ratio of those who did not
complain/who complained = 40% to 75%/60% to 25%), the complaints were sleepy, fatigue and nauseous/ vomit.
TABLE 4. The relationship between the frequency of consumption of kratom leaves with complaints
complaint
Of- Exes- sudden
Frequency Nau- Exces- no Total
Fati- ten sive weight
aches Sleepy seous/ sive com-
gue sick- swea- gain or
vomit thirst plaints
ly thing loss
three
times a 0 0 0 0 0 1 0 0 2 3
day
twice a
0 1 2 0 0 0 0 0 7 10
day
once a
4 6 3 3 1 0 0 0 42 59
day
four times
0 1 1 0 0 0 0 0 20 22
a week
three
times a 0 2 1 1 0 0 0 1 17 22
week
twice a
0 0 1 0 0 0 0 0 8 9
week
once a
0 1 1 2 0 0 1 0 14 19
week
three
times a 0 1 1 1 0 0 0 0 20 23
month
twice a
5 0 2 0 0 0 0 0 16 23
month
once a
1 0 2 2 0 0 0 0 42 47
month
Total 10 12 14 9 1 1 1 1 188 237
050026-9
The results of the chi-quadrate test of the relationship between the frequency of consumption of kratom leaves
with complaints showed that there was a very significant relationship, as shown in Table 1. Most respondents stated
that they had no complaints with the consumption of kratom leaves (Table 4). The ratio of respondents who have
complaints/no complaints is 9-33%/67-91%. The highest complaint was on the frequency of drinking kratom leaves
three times a day. The most complaints in this frequency and dose were sleepiness (6 statements), aches and fatigue,
4 and 3 statements, respectively.
CONCLUSIONS
Kratom leaves are used by the people of Kapuas Hulu Regency as a medicine to maintain and increase stamina,
overcome fatigue, reduce high blood pressure, relieve aches, treat wounds, relieve pain, relieve diarrhea and stomach
pain, treat diabetes, treat alcohol addiction, treat coughs, treat malaria, treat sex disorder, relieve skin itching, and
reduce fever. Generally, people who consume kratom leaves experience no complaints, few experience complaints.
These complaints are feeling tired, sleepy and stiff.
ACKNOWLEDGEMENTS
The authors express their gratitude to the Research and Development Agency of West Kalimantan Province that
supported the fund for this research.
REFERENCE
1. F. Gong, H. P. Gu, Q. T. Xu, W. Y. Kang, Genus Mitragyna: Ethnomedicinal uses and pharmacological studies,
Phytopharmacology, 3(2) 263-272 (2012).
2. V. Meireles, T. Rosado, M. Barroso, S. Soares, J. Gonçalves, Â. Luís, D. Caramelo, A. Y. Simão, N. Fernández,
A. P. Duarte and E. Gallardo, Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological
and Non-Biological Samples, Medicines, 6(35): 1-21 (2019).
3. Z. Hassan, M. Muzaimi, V. Navaratnam, N. H. M. Yusoff, F. W. Suhaimi, R. Vadivelu, B. K. Vicknasingam, D.
Amato, S. V. Hörsten, N. I. W. Ismail, N. Jayabalan, A. I. Hazim, S. M. Mansor, C. P. Müller, From Kratom to
mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction,
Neuroscience and Biobehavioral Reviews, 37: 138–151 (2013).
4. C. Veltri and O. Grundmann, Current perspectives on the impact of Kratom use, Substance Abuse and
Rehabilitation, 10: 23–31 (2019).
5. D. Fluyau and N. Revadigar, Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom, Frontier
in Psychiatry, 8(62): 1-8 (2017).
6. L. Elsa, M.Yuwono dan A. Prawita, Pengembangan metode isolasi dan identifikasi mitragynine dalam daun
kratom (Mitragyna speciosa), Jurnal Biosains Pascasarjana, 18(3): 1-13 (2016).
7. Y. S. Goh, T. Karunakaran, V. Murugaiyah, R. Santhanam, M. H. A. Bakar and S. Ramanathan, Accelerated
Solvent Extractions (ASE) of Mitragyna speciosa Korth. (Kratom) Leaves: Evaluation of Its Cytotoxicity and
Antinociceptive Activity, Molecules, 26(3704): 1-16 (2021).
8. D. Singh, S. Narayanan, O. Grundmann, N. J. Y. Chear, V. Murugaiyah, S. B. S. Hamid, N. S. M. Yusof, E. B.
Dzulkapli, V. Balasingam, Long-Term Effects of Kratom (Mitragyna speciosa) Use, Malaysian Journal of
Medicine and Health Sciences, 16(4): 64-72 (2020)
9. S. Parthasarathy, J. B. Azizi, S. Ramanathan, S. Ismail, S. Sasidharan, M. I. M. Said and S. M. Mansor,
Evaluation of Antioxidant and Antibacterial Activities of Aqueous, Methanolic and Alkaloid Extracts from
Mitragyna Speciosa (Rubiaceae Family) Leaves, Molecules, 14: 3964-3974 (2009).
10. M. L. Warner, N. C. Kaufman and O. Grundmann, The pharmacology and toxicology of kratom: from traditional
herb to drug of abuse, Int J Legal Med, 130:127–138 (2016).
11. N. Harun, Z. Hassan, V. Navaratnam, S. M. Mansor, M. Shoaib, Discriminative stimulus properties of
mitragynine (kratom) in rats, Psychopharmacology 232:2227–2238 (2015).
12. L. Boffa, C. Ghè, A. Barge, G. Muccioli and G. Cravotto, Alkaloid Profiles and Activity in Different Mitragyna
speciosa Strains, Natural Product Communications, 13(9): 1111 – 1116 (2018).
13. W. C. Prozialeck, J. R. Edwards, P. C. Lamar, B. J. Plotkin, I. M. Sigar, O. Grundmann and C. A. Veltri,
Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products
050026-10
Purchased in theWestern Suburbs of Chicago, International Journal of Environmental Research and Public
Health, 17(5512):1-13 (2020).
14. C.A. Criddle, A Comparison of Mitrgyna speciosa and mitragynine against opioids on thermal nociception in
rats, Thesis, University of Mississippi, Oxford, 2015, 1-18 pp.
15. O. B. Ahmad, C. Boschi-Pinto, A. D. Lopez, C. J. Murray, R. Lozano and M. Inoue, Age standardization of
rates: a new WHO standard. GPE Discussion Paper Series: No.31, EIP/GPE/EBD, World Health Organization
(2001) 1-14 pp.
16. J. W. Low, A. Leela and S. J. Bhore, The Kratom Plant [Mitragyna speciosa (Korth.)] Paradox: Beneficial or
Detrimental? Biosensors, Biodiagnostics, Biochips and Biotechnology Res. Highl. 4Bs (2016), P84-89.
17. W. M. S. Mossadeq, M.R. Sulaiman, T.A. Tengku Mohamad, H.S. Chiong, Z.A. Zakaria, M.L. Jabit, M.T.H.
Baharuldin, D.A. Israf, Anti-Inflammatory and Antinociceptive Effects of Mitragyna speciosa Korth Methanolic
Extract, Med Princ Pract (18): 378–384 (2009).
18. E. Juanda, S. Andayani, Maftuch, Phytochemical Screening and Antibacterial Activity of Kratom Leaf
(Mitragyna speciosa Korth.) Against Aeromonas hydrophilla. J.Exp. Life Sci. Vol. 9 No. 3 (2019).
19. H. Puspasari, Suhaimi, Husnani, I. F. Krismonika, Uji daya hambat ekstrak kental daun kratom (Mitragyna
speciosa Korth) terhadap pertumbuhan bakteri Staphylococcus epidermidis sebagai penyebab jerawat, Medical
Sains, 4(2): 87-94 (2020).
20. Rabani, F. Diba, Muflihati, Inhibition of Fungal Growth Schizophillum commune Fries by Ethanol extract of
leaves of Kratom (Mitragyna speciosa Korth), Jurnal Hutan Lestari, 5(3): 831 – 839 (2017).
21. D. Singh, T. Damodaran, W. C. Prozialeck, O. Grundmann, T. Karunakaran and B. Vicknasingama, Constipation
prevalence and fatigue severity in regular kratom (Mitragyna speciosa Korth.) users, Journal of Substance Use,
2018a.
22. D. Singh, S. Narayanan, B. K. Vicknasingam, W. C. Prozialeck, S. Ramanathan, H. Zainal and S. N. Harun,
Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular
Kratom Users, Journal of Psychoactive Drugs: 1-9 (2018b).
23. V. Singh, N. Mulla, J. L. Wilson, A. Umansky, J. Lee, T. Stead and L. Ganti, Intractable nausea and vomiting in
naïve ingestion of kratom for analgesia, International Journal of Emergency Medicine, 13(42): 1-4 (2020).
24. R. Benyamin, A. M. Trescot, S. Datta, R. Buenaventura, R. Adlaka, N. Sehgal, S. E. Glaser and R. Vallejo,
Opioid Complications and Side Effects. Pain Physician 2008: Opioid Special Issue: 11:S105-S120 (2008).
25. E. Cinosi, D. Singh, G. Martinotti, Z. Demetrovics, F.S. Bersani, J.H. Li, W.j. Yu, M.D. Giannantonio, P.
Simonato, A. Roman-Urrestarazu, B. Vicknasingam, M. Kapitány-Fövény, and O. Corazza, Following (the
Roots) of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work
and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries, Hindawi
Publishing Corporation, BioMed Research International: 1-11 (2015).
26. A.R. Shamima, S. Fakurazi, M.T. Hidayat, I. Hairuszah, M.A.M. Moklas, and P. Arulselvan, Antinociceptive
Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor System,
International Journal of Molecular Sciences, 13: 11427-11442 (2012).
27. H. Takayama, Chemistry and Pharmacology of Analgesic Indole Alkaloids from the Rubiaceous Plant,
Mitragyna speciosa, Chem. Pharm. Bull. 52(8): 916—928 (2004).
28. G.T. Beng, M.R. Hamdan, M.J. Siddiqui, M.N. Mordi, and S.M. Mansor, A simple and cost effective isolation
and purification protocol of mitragynine from Mitragyna speciosa Korth (Ketum) leaves, The Malaysian Journal
of Analytical Sciences, 15(1): 54 – 60 (2011).
050026-11